Study: Arming The Immune System To Recognize Foreign Invaders
New TGen Study To Combat Pancreatic Cancer The Seena Magowitz Foundation Releases $200,000 Toward A Total Grant of $1 Million To Fund The Study The Translational Genomics Research Institute (TGen), an
New Novel Way To Reverse Pancreatic Cancer
Scientists At Purdue University Reverse Pancreatic Cancer Progression In A “Time Machine” Made of Human Cells Purdue University Engineers Have Shown A Novel Way To Reverse The Course ofMay 1, 2021 Episode of the Voice of Pancreatic Cancer Podcast
Voice of Pancreatic Cancer Podcast MAY 1, 2021 EPISODE: “The PANCREAS Clinical Trial” The PANCREAS Clinical Trial was officially launched by the LaBahn Pancreatic Cancer Program at the Medical College
Clinical Trial Funded By The Seena Magowitz Foundation
Announcing The Launch of “THE PANCREAS Clinical Trial” The “PANCREAS” Clinical Trial By the Medical College of Wisconsin and Partly Funded By The Seena Magowitz Foundation Contribting Writer Tony Subia
Hereditary Pancreatic Cancer
Every Pancreatic Cancer PatientShould Consider Genetic Testing Contributing Writer Tony Subia February 22, 2021 Cancer which include pancreatic cancer is caused by genetic mutations. Each cell in your body has
Combining CRP and CA19-9 In A Prognostic Score in PDAC
Combining CRP and CA19-9 in A Prognostic Score in PDAC Original Article: https://www.nature.com/articles/s41598-020-80778-0 Download PDF Helsinki University Hospital January 12, 2021 Creative Commons Attribution
Pancreatic Cancer Patients Respond To CD Immuontherapy
New Biomarker May Predict Which Patients Respond To CD40 Source: Penn Medicine Abramson Cancer Center News Release: February 4, 2021 Modified For Style and Length By The Seena Magowitz Foundation
Why PDCA Tumors Are So Resistant To Treatment
Why Pancreatic Cancer Tumors Are So Resistant To Treatment Source: Cold Spring Harbor Laboratory Based Upon Its Press Release. February 23, 2017 Edited For Style and Length The Primary Reason
PCDA Stroma Shell Protects Its Tumors
Dense Stroma Impedes Anti-Cancer Drugs From Their Target Researchers Were Able To Determine Which Signals Encourage Fibroblast Cells To Protect or Hinder The Tumor Article Based On Press Release (October,
PDAC Cells Sabotage Immune System’s Attack On Tumors
Pancreatic Cancer Cells Secrete Signal that Sabotages Immune Attack on Tumors Article Based On NYU Grossman School of Medicine Originally Published January 8, 2020 Edited For Style and Length January
